{"product_id":"rising-contagious-diseases-isbn-9781394188710","title":"Rising Contagious Diseases","description":"\u003cp\u003e\u003cb\u003eComprehensive yet succinct insight into the prevention, diagnosis, and treatment of infectious diseases including COVID-19, mpox, Ebola, and Lyme disease\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003ci\u003eRising Contagious Diseases\u003c\/i\u003e provides basic information about preventing and treating threatening infectious diseases from viral, bacterial, and parasitic sources, including 28 emerging or recurring diseases like COVID-19, mpox, Ebola, bird and swine flu, malaria, Legionnaires', and others. The text highlights molecular surveillance and epidemiology (including zoonotic pathogens or their variants), innovative strategies for pathogen detection, drug and vaccine development, appropriate preventive measures, cost-effective diagnostic procedures (assays), and effective therapeutic strategies.\u003c\/p\u003e \u003cp\u003eThe text is unique due to its broad coverage of today's infectious diseases, covering several which are not similarly addressed elsewhere, with detailed insight from experts around the world.\u003c\/p\u003e \u003cp\u003eComposed of 30 chapters of fundamental facts alongside practical and clinical data, \u003ci\u003eRising Contagious Diseases\u003c\/i\u003e covers sample topics such as:\u003c\/p\u003e \u003cul\u003e \u003cli\u003eRe-emergence of certain diseases in recent decades due to dynamic host-pathogen interactions, anthropogenic selection, and climate change\u003c\/li\u003e \u003cli\u003eHow real-time epidemiological surveillance can improve detection of infectious disease outbreaks or new infections of public health importance\u003c\/li\u003e \u003cli\u003eUp-to-date insight on transmission dynamics, epidemiology, clinical manifestation, advances in diagnostics, and management of covered diseases\u003c\/li\u003e \u003cli\u003eEffects of disease outbreaks on the world at large, such as through high morbidity and mortality rates and rising healthcare costs\u003c\/li\u003e \u003c\/ul\u003e \u003cp\u003eWith detailed insight on the prevention, diagnosis, and treatment of infectious diseases, \u003ci\u003eRising Contagious Diseases\u003c\/i\u003e is an essential reference for health care professionals, academics in the field of microbiology, immunology, infectious diseases, pathology, pharmacology and public health, and undergraduates and postgraduates in related disciplines.\u003c\/p\u003e \u003cp\u003eList of Contributors xxv\u003c\/p\u003e \u003cp\u003eForeword xxxi\u003c\/p\u003e \u003cp\u003ePreface xxxii\u003c\/p\u003e \u003cp\u003eBiographies xxxiii\u003c\/p\u003e \u003cp\u003e\u003cb\u003e1 Emerging and Re-Emerging Infectious Diseases of the Decade: An Overview 1\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eRanjita Shegokar, Seth K. Amponsah, and Yashwant V. Pathak\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e1.1 Introduction 1\u003c\/p\u003e \u003cp\u003e1.2 Infectious Diseases and the Economy 1\u003c\/p\u003e \u003cp\u003e1.3 The Main Factors Involved in EIDs and REIDs 2\u003c\/p\u003e \u003cp\u003e1.4 Prevention of EIDs and REIDs 3\u003c\/p\u003e \u003cp\u003e1.5 Infectious Diseases of the Last Decades 4\u003c\/p\u003e \u003cp\u003e1.6 Conclusion 6\u003c\/p\u003e \u003cp\u003e\u003cb\u003e2 Recent Trends and Possible Future Trajectory of COVID-19 7\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eIsmaila Adams, Ofosua Adi-Dako, Eugene Boafo, Emmanuel K. Ofori, and Seth K. Amponsah\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e2.1 Introduction 7\u003c\/p\u003e \u003cp\u003e2.2 Overview of COVID-19 8\u003c\/p\u003e \u003cp\u003e2.3 Current State of the Pandemic 10\u003c\/p\u003e \u003cp\u003e2.4 Epidemiological Projections and Modeling 11\u003c\/p\u003e \u003cp\u003e2.5 Potential Scenarios for the Future 12\u003c\/p\u003e \u003cp\u003e2.6 Impact of COVID-19 on Public Health and Healthcare Systems 13\u003c\/p\u003e \u003cp\u003e2.7 Socioeconomic and Behavioral Considerations 14\u003c\/p\u003e \u003cp\u003e2.8 Global Preparedness and Response 15\u003c\/p\u003e \u003cp\u003e2.9 Conclusion and Recommendations 16\u003c\/p\u003e \u003cp\u003e\u003cb\u003e3 Mpox: New Challenges with the Disease 20\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eJulia Wang, Lynn Nguyen, Vernon Volante, Jeannez Daniel, and Charles Preuss\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e3.1 History of Mpox virus 20\u003c\/p\u003e \u003cp\u003e3.2 Characteristics 20\u003c\/p\u003e \u003cp\u003e3.3 Epidemiology 20\u003c\/p\u003e \u003cp\u003e3.4 Transmission 21\u003c\/p\u003e \u003cp\u003e3.5 Pathogenicity 22\u003c\/p\u003e \u003cp\u003e3.6 Risk Factors 23\u003c\/p\u003e \u003cp\u003e3.7 Diagnostic Testing 24\u003c\/p\u003e \u003cp\u003e3.8 Symptoms 24\u003c\/p\u003e \u003cp\u003e3.9 Long-Term Effects and Complications 25\u003c\/p\u003e \u003cp\u003e3.10 Vaccinations 26\u003c\/p\u003e \u003cp\u003e3.11 Epidemic Management 27\u003c\/p\u003e \u003cp\u003e3.12 Pharmacology 28\u003c\/p\u003e \u003cp\u003e3.13 Future Implications 29\u003c\/p\u003e \u003cp\u003e3.14 Conclusion 29\u003c\/p\u003e \u003cp\u003e\u003cb\u003e4 Ebola Virus Disease: Transmission Dynamics and Management 31\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eKshama Patel, Jasmine Primus, Carina Copley, and Yashwant V. Pathak\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e4.1 Introduction 31\u003c\/p\u003e \u003cp\u003e4.2 Transmission Dynamics 33\u003c\/p\u003e \u003cp\u003e4.3 Disease Management 34\u003c\/p\u003e \u003cp\u003e4.4 Morbidity 36\u003c\/p\u003e \u003cp\u003e4.5 Intersections 37\u003c\/p\u003e \u003cp\u003e4.6 Conclusion 39\u003c\/p\u003e \u003cp\u003e\u003cb\u003e5 Avian Influenza Outbreaks over the Last Decade: An Analytical Review and Containment Strategies 42\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eAbdullah Abdelkawi, Zaineb Zinoune, Aliyah Slim, and Yashwant V. Pathak\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e5.1 Background 42\u003c\/p\u003e \u003cp\u003e5.2 Causative Microorganisms 43\u003c\/p\u003e \u003cp\u003e5.3 Strategies for Containment 45\u003c\/p\u003e \u003cp\u003e5.4 Ongoing Investigations and Prospective Look into Avian Influenza 46\u003c\/p\u003e \u003cp\u003e\u003cb\u003e6 Swine Flu: Current Status and Challenges 50\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eLucy Mohapatra, Geeta Patel, Alok S. Tripathi, Alka, Deepak Mishra, Sambit K. Parida, Mohammad Yasir, and Rahul K. Maurya\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e6.1 Introduction 50\u003c\/p\u003e \u003cp\u003e6.2 Current Status – Swine Flu 51\u003c\/p\u003e \u003cp\u003e6.3 Pathogenesis Related to Swine Flu 53\u003c\/p\u003e \u003cp\u003e6.4 Diagnosis 55\u003c\/p\u003e \u003cp\u003e6.5 Treatment and Management of Swine Flu 57\u003c\/p\u003e \u003cp\u003e6.6 Challenges During Combating Swine Flu 58\u003c\/p\u003e \u003cp\u003e6.7 Conclusion 60\u003c\/p\u003e \u003cp\u003e\u003cb\u003e7 Zika Virus Disease: An Emerging Global Threat 66\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eOfosua Adi-Dako, Awo A. Kwapong, and Selorme Adukpo\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e7.1 Introduction 66\u003c\/p\u003e \u003cp\u003e7.2 Epidemiology of the Zika Virus Infection 66\u003c\/p\u003e \u003cp\u003e7.3 Infection and Pathophysiology 67\u003c\/p\u003e \u003cp\u003e7.4 Immune Response and Vaccine 68\u003c\/p\u003e \u003cp\u003e7.5 Zika Virus Infection Diagnosis and Management 69\u003c\/p\u003e \u003cp\u003e7.6 Development of Antiviral Therapeutic Drug against Zika Virus 69\u003c\/p\u003e \u003cp\u003e7.7 The Way Forward 70\u003c\/p\u003e \u003cp\u003e\u003cb\u003e8 Current Perspectives in Dengue Hemorrhagic Fever 72\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eManish P. Patel, Vaishnavi M. Oza, Hemangi B. Tanna, Avinash D. Khadela, Praful D. Bharadia, and Jayvadan K. Patel\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e8.1 Introduction 72\u003c\/p\u003e \u003cp\u003e8.2 Life Cycle of Dengue Mosquitoes 74\u003c\/p\u003e \u003cp\u003e8.3 Life Cycle of Dengue Virus 74\u003c\/p\u003e \u003cp\u003e8.4 Risk Factors Responsible for Dengue Fever 75\u003c\/p\u003e \u003cp\u003e8.5 Pathophysiology of Dengue Fever 75\u003c\/p\u003e \u003cp\u003e8.6 Clinical Manifestation 76\u003c\/p\u003e \u003cp\u003e8.7 Diagnosis of Dengue Fever 78\u003c\/p\u003e \u003cp\u003e8.8 Prevention of Disease 80\u003c\/p\u003e \u003cp\u003e8.9 Management of Dengue Disease 83\u003c\/p\u003e \u003cp\u003e8.10 Conclusion 85\u003c\/p\u003e \u003cp\u003e\u003cb\u003e9 West Nile Virus: Evolutionary Dynamics, Advances in Diagnostics, and Therapeutic Interventions 87\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eBibhuti B. Kakoti, Lawandashisha Nongrang, Chinmoyee Borah, Monali Lahiri, Mainak Ghosh, and Ankit Choudhary\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e9.1 Introduction 87\u003c\/p\u003e \u003cp\u003e9.2 Geographical Distribution 88\u003c\/p\u003e \u003cp\u003e9.3 The Virus and its Genome 89\u003c\/p\u003e \u003cp\u003e9.4 Etiology and Pathogenesis 90\u003c\/p\u003e \u003cp\u003e9.5 Relationship Between Host-Pathogen in West Nile Virus Infection 92\u003c\/p\u003e \u003cp\u003e9.6 Clinical Presentation of West Nile Virus 93\u003c\/p\u003e \u003cp\u003e9.7 Management of West Nile Virus 95\u003c\/p\u003e \u003cp\u003e9.8 Recent Advancements in Diagnostics, Clinical Assessment, and Treatment 96\u003c\/p\u003e \u003cp\u003e9.9 Conclusion and Future Prediction 98\u003c\/p\u003e \u003cp\u003e\u003cb\u003e10 Hantavirus Disease: A Global Update over the Last Decade 106\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eAnita Patel, Nisarg Patel, and Jayvadan K. Patel\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e10.1 Introduction 106\u003c\/p\u003e \u003cp\u003e10.2 Life Cycle 106\u003c\/p\u003e \u003cp\u003e10.3 Ecology and Evolution of Hantavirus 108\u003c\/p\u003e \u003cp\u003e10.4 Epidemiology of Hantavirus Infections 111\u003c\/p\u003e \u003cp\u003e10.5 The Clinical Course of Hantavirus Diseases and Pathology 113\u003c\/p\u003e \u003cp\u003e10.6 Laboratory Diagnosis of Hantavirus Infection 114\u003c\/p\u003e \u003cp\u003e10.7 Treatment and Prevention 116\u003c\/p\u003e \u003cp\u003e10.8 Recent Outbreaks of Hantavirus 121\u003c\/p\u003e \u003cp\u003e10.9 Summary and Conclusion 122\u003c\/p\u003e \u003cp\u003e\u003cb\u003e11 Current Advances in Marburg Virus Disease 129\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eEmmanuel K. Ofori and Eric N.Y. Nyarko\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e11.1 Introduction 129\u003c\/p\u003e \u003cp\u003e11.2 Pathogenesis and Pathophysiology of MARV 134\u003c\/p\u003e \u003cp\u003e11.3 Marburg Virus Disease (MVD) 135\u003c\/p\u003e \u003cp\u003e11.4 Conclusion 142\u003c\/p\u003e \u003cp\u003e\u003cb\u003e12 Recent Advances in Combating Nipah Virus Disease 145\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eMehul Chorawala, Aanshi Pandya, Ishika Shah, Bhupendra G. Prajapati, Nirjari Kothari, and Aayushi Shah\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e12.1 Introduction 145\u003c\/p\u003e \u003cp\u003e12.2 Recent Advancements in Nipah Virus Diagnostic Tools 151\u003c\/p\u003e \u003cp\u003e12.3 Recent Development in Therapeutics and Treatment Modalities Against NiV Disease 152\u003c\/p\u003e \u003cp\u003e12.4 Conclusion and Future Directions 158\u003c\/p\u003e \u003cp\u003e\u003cb\u003e13 Middle East Respiratory Syndrome (MERS) 164\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eOrhan E. Arslan\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e13.1 Introduction 164\u003c\/p\u003e \u003cp\u003e13.2 Discussion 165\u003c\/p\u003e \u003cp\u003e13.3 Conclusions 174\u003c\/p\u003e \u003cp\u003e\u003cb\u003e14 Chikungunya Fever: Epidemiology, Clinical Manifestation, and Management 181\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eChandrakanta, Bhupendra G. Prajapati, and Archana N. Sah\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e14.1 Introduction 181\u003c\/p\u003e \u003cp\u003e14.2 Epidemiology 184\u003c\/p\u003e \u003cp\u003e14.3 Clinical Manifestation 186\u003c\/p\u003e \u003cp\u003e14.4 Diagnosis of Chikungunya Fever 189\u003c\/p\u003e \u003cp\u003e14.5 Management of Chikungunya Fever 190\u003c\/p\u003e \u003cp\u003e14.6 Disease Modifying Antirheumatic Drugs 191\u003c\/p\u003e \u003cp\u003e14.7 Non-Pharmacological Treatment 191\u003c\/p\u003e \u003cp\u003e14.8 Medicinal Plants for CHIKV and Its Associated Symptoms 191\u003c\/p\u003e \u003cp\u003e14.9 Future Prospectives 193\u003c\/p\u003e \u003cp\u003e14.10 Conclusion 193\u003c\/p\u003e \u003cp\u003e\u003cb\u003e15 Lassa Fever: Recent Clinical Reports and Management Update 199\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eAbigail Aning, Kwasi A. Bugyei, Bismarck A. Hottor, and Seth K. Amponsah\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e15.1 Background 199\u003c\/p\u003e \u003cp\u003e15.2 Geographical Distribution 199\u003c\/p\u003e \u003cp\u003e15.3 Mode of Transmission 199\u003c\/p\u003e \u003cp\u003e15.4 Reservoir Hosts 199\u003c\/p\u003e \u003cp\u003e15.5 Incidence and Prevalence 200\u003c\/p\u003e \u003cp\u003e15.6 Clinical Presentation 200\u003c\/p\u003e \u003cp\u003e15.7 Diagnostic Methods 201\u003c\/p\u003e \u003cp\u003e15.8 Recent Clinical Reports 201\u003c\/p\u003e \u003cp\u003e15.9 Management and Treatment 202\u003c\/p\u003e \u003cp\u003e15.10 Future Prospects and Research Directions 203\u003c\/p\u003e \u003cp\u003e15.11 Conclusions 204\u003c\/p\u003e \u003cp\u003e\u003cb\u003e16 Lyme Disease Management: Antibiotics and Beyond 207\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eAparoop Das, Kalyani Pathak, Manash P. Pathak, Urvashee Gogoi, and Riya Saikia\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e16.1 Introduction to Lyme Disease 207\u003c\/p\u003e \u003cp\u003e16.2 Modes of Transmission 208\u003c\/p\u003e \u003cp\u003e16.3 Recent Trends in Lyme Disease Management 209\u003c\/p\u003e \u003cp\u003e16.4 Future Directions and Challenges in Lyme Disease Management 214\u003c\/p\u003e \u003cp\u003e16.5 Conclusion 215\u003c\/p\u003e \u003cp\u003e\u003cb\u003e17 Chagas Disease: Historical and Current Trends 220\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eVivek Patel, Dhara Patel, Grishma Patel, and Jayvadan K. Patel\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e17.1 Introduction 220\u003c\/p\u003e \u003cp\u003e17.2 Discovery of Chagas Disease 221\u003c\/p\u003e \u003cp\u003e17.3 Etiology of Chagas Disease 222\u003c\/p\u003e \u003cp\u003e17.4 Lifecycle of T. cruzi 222\u003c\/p\u003e \u003cp\u003e17.5 Clinical Forms of Chagas Disease 223\u003c\/p\u003e \u003cp\u003e17.6 Diagnosis and Management of Chagas Disease 224\u003c\/p\u003e \u003cp\u003e17.7 Conclusion 231\u003c\/p\u003e \u003cp\u003e\u003cb\u003e18 Legionnaires’ Disease: Current Trends in Microbiology and Pharmacology 237\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eJulia Wang, Neha Chintapally, Meera Nagpal, Anjali Mahapatra, and Charles Preuss\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e18.1 History of Legionella spp. 237\u003c\/p\u003e \u003cp\u003e18.2 Bacterial Life Cycle 238\u003c\/p\u003e \u003cp\u003e18.3 Pathogenicity 238\u003c\/p\u003e \u003cp\u003e18.4 Alterations to Host Cell Pathways 239\u003c\/p\u003e \u003cp\u003e18.5 Ubiquitin Pathways 240\u003c\/p\u003e \u003cp\u003e18.6 Legionella-Amoeba Interactions 241\u003c\/p\u003e \u003cp\u003e18.7 Risk Factors 241\u003c\/p\u003e \u003cp\u003e18.8 Detection\/Diagnostic Testing 241\u003c\/p\u003e \u003cp\u003e18.9 Symptoms 242\u003c\/p\u003e \u003cp\u003e18.10 Long-Term Effects and Co-morbidities 243\u003c\/p\u003e \u003cp\u003e18.11 Prevention 243\u003c\/p\u003e \u003cp\u003e18.12 Pharmacology 244\u003c\/p\u003e \u003cp\u003e18.13 Treatments in Development 245\u003c\/p\u003e \u003cp\u003e18.14 New Technologies 246\u003c\/p\u003e \u003cp\u003e18.15 Conclusion 248\u003c\/p\u003e \u003cp\u003e\u003cb\u003e19 Babesiosis: An Emerging Global Threat 253\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eKomal Parmar and Jayvadan K. Patel\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e19.1 Introduction 253\u003c\/p\u003e \u003cp\u003e19.2 World-Wide Babesiosis Human Infection 253\u003c\/p\u003e \u003cp\u003e19.3 Life Cycle and Transmission 255\u003c\/p\u003e \u003cp\u003e19.4 Clinical Features, Pathogenesis, and Diagnosis of Babesiosis 256\u003c\/p\u003e \u003cp\u003e19.5 Management of Babesiosis 256\u003c\/p\u003e \u003cp\u003e19.6 Conclusion 257\u003c\/p\u003e \u003cp\u003e\u003cb\u003e20 Epidemiology and Current Trends in Malaria 261\u003cbr\u003e\u003c\/b\u003e\u003ci\u003ePriya Patel, Arti Bagada, and Nasir Vadia\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e20.1 History of Malaria 261\u003c\/p\u003e \u003cp\u003e20.2 Types of Malaria 262\u003c\/p\u003e \u003cp\u003e20.3 Worldwide Trend of Malaria (Geographical and Country)\/The Spatial Epidemiology of Malaria Globally 264\u003c\/p\u003e \u003cp\u003e20.4 History of Malaria Control by Various Authorities\/Agencies 267\u003c\/p\u003e \u003cp\u003e20.5 Diagnosis and Treatment 270\u003c\/p\u003e \u003cp\u003e20.6 Prevention and Elimination of Malaria 272\u003c\/p\u003e \u003cp\u003e20.7 Vaccine for Malaria and Current Trends of Malaria Treatment 273\u003c\/p\u003e \u003cp\u003e20.8 Challenges for National Governments 275\u003c\/p\u003e \u003cp\u003e20.9 Malaria Eradication Programme 276\u003c\/p\u003e \u003cp\u003e20.10 Conclusion 278\u003c\/p\u003e \u003cp\u003e\u003cb\u003e21 Cryptosporidiosis: Recent Advances in Diagnostics and Management 283\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eSubhasundar Maji, Moitreyee Chattopadhyay, Debankini Dasgupta, Ananya Chanda, and Sandipan Dasgupta\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e21.1 Introduction 283\u003c\/p\u003e \u003cp\u003e21.2 Epidemiology 284\u003c\/p\u003e \u003cp\u003e21.3 What Is Cryptosporidium? 284\u003c\/p\u003e \u003cp\u003e21.4 Mechanism of Cryptosporidium Infection 286\u003c\/p\u003e \u003cp\u003e21.5 Diagnostic Methods 287\u003c\/p\u003e \u003cp\u003e21.6 Management 288\u003c\/p\u003e \u003cp\u003e21.7 Prevention and Control 291\u003c\/p\u003e \u003cp\u003e21.8 Future Perspectives 293\u003c\/p\u003e \u003cp\u003e21.9 Conclusion 294\u003c\/p\u003e \u003cp\u003e\u003cb\u003e22 Leishmaniasis: Current Trends in Microbiology and Pharmacology 297\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eIsmaila Adams, Awo A. Kwapong, Eugene Boafo, Elizabeth Twum, and Seth K. Amponsah\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e22.1 Introduction 297\u003c\/p\u003e \u003cp\u003e22.2 Leishmania Species and Clinical Manifestations 298\u003c\/p\u003e \u003cp\u003e22.3 Microbiology of Leishmania 299\u003c\/p\u003e \u003cp\u003e22.4 Diagnosis of Leishmaniasis 301\u003c\/p\u003e \u003cp\u003e22.5 Drug Therapy for Leishmaniasis 303\u003c\/p\u003e \u003cp\u003e22.6 Drug Resistance in Leishmania 304\u003c\/p\u003e \u003cp\u003e22.7 Strategies to Overcome Drug Resistance in Leishmania 305\u003c\/p\u003e \u003cp\u003e22.8 New Developments in Antileishmanial Drugs 306\u003c\/p\u003e \u003cp\u003e22.9 Repurposing Existing Drugs 308\u003c\/p\u003e \u003cp\u003e22.10 Vector Control and Leishmaniasis Prevention 309\u003c\/p\u003e \u003cp\u003e22.11 Conclusion 309\u003c\/p\u003e \u003cp\u003e\u003cb\u003e23 Recent Trends in Toxoplasmosis Diagnosis and Management 314\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eMehul Chorawala, Nirjari Kothari, Aayushi Shah, Aanshi Pandya, Ishika Shah, and Bhupendra G. Prajapati\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e23.1 Introduction 314\u003c\/p\u003e \u003cp\u003e23.2 Recent Advances in Diagnosis 319\u003c\/p\u003e \u003cp\u003e23.3 Current Management of Toxoplasmosis 321\u003c\/p\u003e \u003cp\u003e23.4 Need for Novel Treatment 324\u003c\/p\u003e \u003cp\u003e23.5 Novel or Repurposed Therapeutic Molecules as Anti-Toxoplasma Activity 324\u003c\/p\u003e \u003cp\u003e23.6 Conclusion and Outlook 329\u003c\/p\u003e \u003cp\u003e\u003cb\u003e24 Recent Trends in Neurocysticerosis Diagnosis and Management 337\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eSachin P. Bhatt, Avani N. Joshi, and Bhupendra G. Prajapati\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eAbbreviations 337\u003c\/p\u003e \u003cp\u003e24.1 Introduction 337\u003c\/p\u003e \u003cp\u003e24.2 Immunologic Diagnosis 341\u003c\/p\u003e \u003cp\u003e24.3 Management Approaches by Neurocysticercosis Form 344\u003c\/p\u003e \u003cp\u003e24.4 Conclusion 347\u003c\/p\u003e \u003cp\u003e\u003cb\u003e25 Trichinosis: History and Current Trends 351\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eMoitreyee Chattopadhyay, Sandipan Dasgupta, Ananya Chanda, Subhasundar Maji, and Shwetlana Bandyopadhyay\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e25.1 Background 351\u003c\/p\u003e \u003cp\u003e25.2 Historical Reports of Trichinosis Infection 351\u003c\/p\u003e \u003cp\u003e25.3 The Discovery of Trichinosis 352\u003c\/p\u003e \u003cp\u003e25.4 Major Outbreaks of Trichinosis 353\u003c\/p\u003e \u003cp\u003e25.5 Trichinosis Episodes in Animals 356\u003c\/p\u003e \u003cp\u003e25.6 The Nematode: Trichinella sp. 358\u003c\/p\u003e \u003cp\u003e25.8 Control of Trichinella Infection in Humans 363\u003c\/p\u003e \u003cp\u003e25.9 Current Trend in Trichinella Epidemiology 363\u003c\/p\u003e \u003cp\u003e25.10 Conclusion 364\u003c\/p\u003e \u003cp\u003e\u003cb\u003e26 Schistosomiasis: Recent Clinical Reports and Management 368\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eEmmanuel K. Ofori and Akua O. Forson\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e26.1 Introduction 368\u003c\/p\u003e \u003cp\u003e26.2 Parasitology Diagnosis 371\u003c\/p\u003e \u003cp\u003e26.3 Biomarkers: Screening, Detection of Worm Antigens and Specific Antibodies 371\u003c\/p\u003e \u003cp\u003e26.4 Radiology 372\u003c\/p\u003e \u003cp\u003e26.5 Management 372\u003c\/p\u003e \u003cp\u003e26.6 Conclusion 374\u003c\/p\u003e \u003cp\u003e\u003cb\u003e27 Granulomatous Amebic Encephalitis: Evolutionary Dynamics, Advances in Diagnostics and Therapeutic Interventions 378\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eLucy Mohapatra, Alok S. Tripathi, Bhupendra G. Prajapati, Alka, Deepak Mishra, Mohammad Yasir, and Rahul K. Maurya\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e27.1 Introduction 378\u003c\/p\u003e \u003cp\u003e27.2 Epidemiology for Granulomatous Amebic Encephalitis 379\u003c\/p\u003e \u003cp\u003e27.3 Pathogenesis of Granulomatous Amebic Encephalitis 379\u003c\/p\u003e \u003cp\u003e27.4 Evolutionary Dynamics Involved in Granulomatous Amebic Encephalitis 383\u003c\/p\u003e \u003cp\u003e27.5 Diagnosis for Granulomatous Amebic Encephalitis 385\u003c\/p\u003e \u003cp\u003e27.6 Advances in Therapeutic Interventions for Granulomatous Amebic Encephalitis 387\u003c\/p\u003e \u003cp\u003e27.7 Conclusion 389\u003c\/p\u003e \u003cp\u003e\u003cb\u003e28 Epidemiology and Current Treatment Trends in “Thelaziasis” 396\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eRihana B. Patnool, Badrud D. Mohammad, Vishwas H. Nagendra, Bhupendra G. Prajapati, Muhasina K. Muhamadkazim, and Sivasankaran Ponnusankar\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e28.1 Introduction 396\u003c\/p\u003e \u003cp\u003e28.2 Causative Agents 397\u003c\/p\u003e \u003cp\u003e28.3 Morphology 399\u003c\/p\u003e \u003cp\u003e28.4 Mode of Transmission 402\u003c\/p\u003e \u003cp\u003e28.5 Hosts and Vectors 403\u003c\/p\u003e \u003cp\u003e28.6 Life Cycle of Thelazia Species 405\u003c\/p\u003e \u003cp\u003e28.7 Molecular Acumens of Thelaziasis Species 406\u003c\/p\u003e \u003cp\u003e28.8 Geographical Distribution 406\u003c\/p\u003e \u003cp\u003e28.9 Clinical Presentations of Thelaziasis 407\u003c\/p\u003e \u003cp\u003e28.10 Diagnosis of Thelaziasis 407\u003c\/p\u003e \u003cp\u003e28.11 Treatment Options for Thelaziasis 407\u003c\/p\u003e \u003cp\u003e28.12 Precautionary Measures 408\u003c\/p\u003e \u003cp\u003e28.13 Preventive Measures for Thelaziasis 408\u003c\/p\u003e \u003cp\u003e28.14 Recent Trends in Thelaziasis Control 409\u003c\/p\u003e \u003cp\u003e28.15 Conclusion 409\u003c\/p\u003e \u003cp\u003e\u003cb\u003e29 Trypanosomiasis: Current Trends in Microbiology and Pharmacology 411\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eVerner N. Orish\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e29.1 Introduction 411\u003c\/p\u003e \u003cp\u003e29.2 History 412\u003c\/p\u003e \u003cp\u003e29.3 Parasite 413\u003c\/p\u003e \u003cp\u003e29.4 Epidemiology of Human African Trypanosomiasis (HAT) 416\u003c\/p\u003e \u003cp\u003e29.5 Life Cycle of Trypanosoma 417\u003c\/p\u003e \u003cp\u003e29.6 Other Mechanisms of Transmission 418\u003c\/p\u003e \u003cp\u003e29.7 Pathogenesis of HAT 419\u003c\/p\u003e \u003cp\u003e29.8 Clinical Manifestations 420\u003c\/p\u003e \u003cp\u003e29.9 Diagnosis 420\u003c\/p\u003e \u003cp\u003e29.10 Treatment 421\u003c\/p\u003e \u003cp\u003e29.11 Control and Prevention 423\u003c\/p\u003e \u003cp\u003e29.12 Challenges of Control and Prevention 424\u003c\/p\u003e \u003cp\u003e29.13 Conclusion 424\u003c\/p\u003e \u003cp\u003e\u003cb\u003e30 Emerging and Re-Emerging Infectious Diseases of the Decade: Current Challenges and Future Directions 428\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eSeth K. Amponsah, Ranjita Shegokar, and Yashwant V. Pathak\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e30.1 Introduction 428\u003c\/p\u003e \u003cp\u003e30.2 Factors Leading to the Emergence and Re-Emergence of Infectious Diseases 429\u003c\/p\u003e \u003cp\u003e30.3 Current Challenges of Emerging and Re-Emerging Infectious Diseases 430\u003c\/p\u003e \u003cp\u003e30.4 Strategies\/Possible Interventions 431\u003c\/p\u003e \u003cp\u003e30.5 Future Directions 433\u003c\/p\u003e \u003cp\u003e30.6 Conclusion 434\u003c\/p\u003e \u003cp\u003eReferences 434\u003c\/p\u003e \u003cp\u003eIndex 438\u003c\/p\u003e  \u003cp\u003e\u003cb\u003eSeth Kwabena Amponsah,\u003c\/b\u003e MPhil, PhD is Head of the Department of Medical Pharmacology, University of Ghana Medical School, Accra, Ghana. He has published over 40 research articles, three book chapters, and edited a book.  \u003c\/p\u003e\u003cp\u003e\u003cb\u003eRanjita Shegokar,\u003c\/b\u003e PhD, MBA is Chief Scientific Officer (CSO) at Capnopharm GmbH, Tuebingen, Germany. She has authored several research articles and book chapters. \u003c\/p\u003e\u003cp\u003e\u003cb\u003eYashwant V. Pathak,\u003c\/b\u003e PhD is Professor and Associate Dean for Faculty Affairs at College of Pharmacy, University of South Florida, Florida, USA.   \u003c\/p\u003e\u003cp\u003e\u003cb\u003eComprehensive yet succinct insight into the prevention, diagnosis, and treatment of infectious diseases including COVID-19, mpox, Ebola, and Lyme disease\u003c\/b\u003e \u003c\/p\u003e\u003cp\u003e\u003ci\u003eRising Contagious Diseases\u003c\/i\u003e provides basic information about preventing and treating threatening infectious diseases from viral, bacterial, and parasitic sources, including 28 emerging or recurring diseases like COVID-19, mpox, Ebola, bird and swine flu, malaria, Legionnaires’, and others. The text highlights molecular surveillance and epidemiology (including zoonotic pathogens or their variants), innovative strategies for pathogen detection, drug and vaccine development, appropriate preventive measures, cost-effective diagnostic procedures (assays), and effective therapeutic strategies. \u003c\/p\u003e\u003cp\u003eThe text is unique due to its broad coverage of today’s infectious diseases, covering several which are not similarly addressed elsewhere, with detailed insight from experts around the world. \u003c\/p\u003e\u003cp\u003eComposed of 30 chapters of fundamental facts alongside practical and clinical data, \u003ci\u003eRising Contagious Diseases\u003c\/i\u003e covers sample topics such as: \u003c\/p\u003e\u003cul\u003e\n\u003cli\u003e Re-emergence of certain diseases in recent decades due to dynamic host-pathogen interactions, anthropogenic selection, and climate change\u003c\/li\u003e \u003cli\u003e How real-time epidemiological surveillance can improve detection of infectious disease outbreaks or new infections of public health importance\u003c\/li\u003e \u003cli\u003e Up-to-date insight on transmission dynamics, epidemiology, clinical manifestation, advances in diagnostics, and management of covered diseases\u003c\/li\u003e \u003cli\u003e Effects of disease outbreaks on the world at large, such as through high morbidity and mortality rates and rising healthcare costs\u003c\/li\u003e\n\u003c\/ul\u003e \u003cp\u003eWith detailed insight on the prevention, diagnosis, and treatment of infectious diseases, \u003ci\u003eRising Contagious Diseases\u003c\/i\u003e is an essential reference for health care professionals, academics in the field of microbiology, immunology, infectious diseases, pathology, pharmacology and public health, and undergraduates and postgraduates in related disciplines.\u003c\/p\u003e","brand":"Wiley","offers":[{"title":"Default Title","offer_id":47989965258981,"sku":"NP9781394188710","price":295.0,"currency_code":"USD","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1842\/7735\/files\/9781394188710.jpg?v=1761786056","url":"https:\/\/k12savings.com\/products\/rising-contagious-diseases-isbn-9781394188710","provider":"K12savings","version":"1.0","type":"link"}